RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Stockholders' equity

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Dec 31, 20245,380-33.79%
Dec 31, 20238,126-6.50%
Dec 31, 20228,691-22.71%
Dec 31, 202111,244+1.65%
Dec 31, 202011,061-26.57%
Dec 31, 201915,063-4.63%
Dec 31, 201815,794-15.74%
Dec 31, 201718,745-46.43%
Dec 31, 201634,993+16.93%
Dec 31, 201529,927+28.14%
Dec 31, 201423,355+3.18%
Dec 31, 201322,636-1.01%
Dec 31, 201222,867+2.35%
Dec 31, 201122,343+1.55%
Dec 31, 201022,002

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)